Cancer cells having high CC scores from the NCI60 panel were shown to be more sensitive to TACC3 inhibitor, BO-264 (Supplementary Fig. S2F), further suggesting the critical involvement of TACC3 in mediating CC and cell survival. The gene discussed is TACC3; the disease is cancer.